Culmination Pharmaceuticals Private Limited
About Culmination Pharmaceuticals Private Limited
Data last updated:
Culmination Pharmaceuticals Private Limited was a private limited company based in Kolkata, West Bengal, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 05 January 2015.
The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2015PTC204812.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sweta Saraf and Manoj Kumar Bajaj.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Kolkata, West Bengal.
As per the financials filed for FY 2018, the company reported a revenue of ₹1.86 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹712 (net margin -0.4%) and EBITDA of ₹5,520 (EBITDA margin 3%).
Company details
Contact details
Culmination Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPratibha Enclave 23 Canal Street 3rd Floor Flat No. 30, 7, Kolkata, West Bengal, India – 700048
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Culmination Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Culmination Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Culmination Pharmaceuticals Private Limited, buy the company report.
Financials of Culmination Pharmaceuticals Private Limited
FY 2018 filings availableCulmination Pharmaceuticals Private Limited reported revenue of ₹1.86 Lakh (down 25% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year. EBITDA fell 59% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5,520 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹712 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3% | |||
| Net Profit Margin | -0.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Culmination Pharmaceuticals Private Limited, buy the company report.
Board of directors of Culmination Pharmaceuticals Private Limited
Culmination Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sweta Saraf | Director | 05 Jan 2015 | 11 Years 9 Months | As last reported |
| Manoj Kumar Bajaj Also directs: Living Healthy 24 Healthcare Private Limited | Director | 05 Jan 2015 | 11 Years 9 Months | As last reported |
Auditor
Culmination Pharmaceuticals Private Limited is audited by PODDAR AGARWAL & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PODDAR AGARWAL & CO | FY 2017 | 329486E |
Shareholding
The shareholding of Culmination Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Culmination Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Culmination Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Culmination Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Culmination Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Culmination Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Manoj Kumar Bajaj was appointed as Director on 05 Jan 2015.
Frequently asked questions
Culmination Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Culmination Pharmaceuticals was a private limited company based in Kolkata, West Bengal, India. The company worked in other hospital and medical care activities, within the healthcare industry. It was incorporated on 05 January 2015 and is registered under CIN U74900WB2015PTC204812. The company has been struck off by the Registrar of Companies and is no longer operational.
Culmination Pharmaceuticals had 2 directors:
- Sweta Saraf - Director
- Manoj Kumar Bajaj - Director
The CIN (Corporate Identification Number) of Culmination Pharmaceuticals is U74900WB2015PTC204812. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Culmination Pharmaceuticals is at Pratibha Enclave 23 Canal Street 3rd Floor Flat No. 30, 7, Kolkata, West Bengal, India – 700048.
Culmination Pharmaceuticals was incorporated on 05 January 2015. It is registered with the Registrar of Companies, Kolkata.
The latest financial statements of Culmination Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
Culmination Pharmaceuticals operated in the healthcare industry, in the other hospital and medical care activities segment. It worked in this industry before it was struck off.
Manoj Kumar Bajaj was appointed as Director on 05 Jan 2015. Sweta Saraf was appointed as Director on 05 Jan 2015.
The compliance status of Culmination Pharmaceuticals is compliant as of 08 August 2026.